Oncobiologics, Inc. reported raising $3.26 Million in an initial SEC Form D filing, from an offering of $40.1 Million
Amount Raised
$3.26 Million
Round Type
Seed
IselinOtherBiotechnologyQuick answer
Outlook Therapeutics raised $3.26 Million in a Seed round, dated September 25, 2017. Outlook Therapeutics is based in Iselin, New Jersey, United States.
- How much did Outlook Therapeutics raise?
- Outlook Therapeutics raised $3.26 Million in a Seed round on September 25, 2017.
- What does Outlook Therapeutics do?
- Outlook Therapeutics is a late clinical-stage biopharmaceutical company working to develop ONS-5010 / LYTENAVA™ (bevacizumab-vikg) as the first FDA-approved ophthalmic formulation of bevacizumab-vikg for use in retinal..
- Where is Outlook Therapeutics based and how big is it?
- Outlook Therapeutics is based in Iselin, New Jersey, United States. Fundz records about 46 employees.
- Who are the decision-makers at Outlook Therapeutics?
- Fundz holds 2 contacts at Outlook Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Outlook Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Emulate, Inc. raised $746K (Seed) on November 9, 2017.
- Anthera Pharmaceuticals Inc raised $2.9M (Seed) on November 9, 2017.
- PROGENITY, INC. raised $50M on November 9, 2017.
- Soligenix raised $2M (Seed) on November 8, 2017.
- Phreesia raised $17M on November 8, 2017.
- Opsonix, Inc. raised $1M (Seed) on November 8, 2017.
Who to call at Outlook Therapeutics, and when
A new round usually means Outlook Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Outlook Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Outlook Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Outlook Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Outlook Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Outlook Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.